首页> 外文OA文献 >Challenges of measuring accurate estradiol levels in aromatase inhibitor-treated postmenopausal breast cancer patients on vaginal estrogen therapy

【2h】

Challenges of measuring accurate estradiol levels in aromatase inhibitor-treated postmenopausal breast cancer patients on vaginal estrogen therapy

机译：在阴道雌激素治疗中测量芳香酶抑制剂治疗后绝经乳腺癌患者的准确雌二醇水平的挑战

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Polly Niravath; Raksha Bhat; Mohamed Al-Ameri; Ahmed AlRawi; Claudette Foreman; Meghana V. Trivedi;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Challenges of measuring accurate estradiol levels in aromatase inhibitor‐treated postmenopausal breast cancer patients on vaginal estrogen therapy [J] . Polly Niravath, Raksha Bhat, Mohamed Al‐Ameri, Pharmacology Research & Perspectives . 2017,第4期

机译：在阴道雌激素治疗下，测量由芳香化酶抑制剂治疗的绝经后乳腺癌患者中准确的雌二醇水平的挑战
2. Effects of Vaginal Estrogens on Serum Estradiol Levels in Postmenopausal Breast Cancer Survivors and Women at Risk of Breast Cancer Taking an Aromatase Inhibitor or a Selective Estrogen Receptor Modulator [J] . Shannon Wills, Anita Ravipati, Padmaja Venuturumilli, Journal of Oncology Practice . 2012,第3期

机译：阴道雌激素对绝经后乳腺癌幸存者和有芳香酶抑制剂或选择性雌激素受体调节剂的乳腺癌风险女性的血清雌二醇水平的影响
3. Higher than expected estradiol levels in aromatase inhibitor-treated, postmenopausal breast cancer patients [J] . KunovacKallakT., BaumgartJ., StavreusEversA., Climacteric: the journal of the International Menopause Society . 2012,第5期

机译：芳香酶抑制剂治疗的绝经后乳腺癌患者的雌二醇水平高于预期
4. Effect of Ubumex Combined with AC-T Sequential Chemotherapy on Serum T Cell Subsets,OPN Levels and Quality of Life in Patients with Triple Negative Breast Cancer [C] . Yan Fan, Wenmin Cai, Sawei Li, International Conference on Biomedical Engineering, Machinery and Earth Science . 2018

机译：ubumex结合AC-T顺序化疗对三重阴性乳腺癌患者血清T细胞亚群，OPN水平和生活质量的影响
5. Predicting Adherence to Aromatase Inhibitor Therapy in Patients with Breast Cancer Using Protection Motivation Theory. [D] . Karmakar, Monita. 2013

机译：使用保护动机理论预测乳腺癌患者对芳香酶抑制剂治疗的依从性。
6. Challenges of measuring accurate estradiol levels in aromatase inhibitor‐treated postmenopausal breast cancer patients on vaginal estrogen therapy [O] . Polly Niravath, Raksha Bhat, Mohamed Al‐Ameri, 2017

机译：在阴道雌激素治疗下测量由芳香化酶抑制剂治疗的绝经后乳腺癌患者中准确的雌二醇水平的挑战
7. Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients [O] . 2013

机译：绝经后乳腺癌患者芳香化酶抑制剂治疗期间用于监测血清雌二醇水平的免疫测定方法的缺陷
8. Obesity and Postmenopausal Breast Cancer Risk: Determining the Role of Growth Factor-Induced Aromatase Expression. [R] . L. Bowers 2014

机译：肥胖和绝经后乳腺癌风险：确定生长因子诱导的芳香酶表达的作用。

Challenges of measuring accurate estradiol levels in aromatase inhibitor-treated postmenopausal breast cancer patients on vaginal estrogen therapy

著录项

引文网络

相似文献

相关主题

期刊订阅